United Therapeutics Corporation

United Therapeutics Corporation annual/quarterly net income history and growth rate from 2021 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• United Therapeutics Corporation net income for the quarter ending March 31, 2026 was 274.9 M, a 14.68% decrease year-over-year.
• United Therapeutics Corporation net income for the twelve months ending March 31, 2026 was 1.2 B, a 7.22% increase year-over-year.
• United Therapeutics Corporation annual net income for 2025 was 1.3 B, a 11.68% increase from 2024.
• United Therapeutics Corporation annual net income for 2024 was 1.2 B, a 21.35% increase from 2023.
• United Therapeutics Corporation annual net income for 2023 was 984.8 M, a 35.40% increase from 2022.
• United Therapeutics Corporation annual net income for 2022 was 727.3 M.